ADME/DMPK Services for Stroke Drugs

Drug metabolism and pharmacokinetics (DMPK) play a key role throughout the stroke drug development process by focusing on the absorption, distribution, metabolism, excretion (ADME), and pharmacokinetic (PK) properties of a stroke drug candidate to help characterize the drug candidate's pharmacology.

At Ace Therapeutics, we have built an experienced DMPK team that can help you design the optimal ADME/DMPK program for your stroke drug discovery and development needs. We can design flexible DMPK screening cascades to support stroke drug development programs, including customized method development.

Our highly trained and experienced scientific team uses validated methodologies that enable all aspects of ADME testing and PK testing, enabling the evaluation of DMPK properties and toxicity of stroke drug candidates in a high data quality, cost-effective manner. Our DMPK services are designed to minimize stroke compound failures, determine the efficacy of targets with acceptable safety profiles, optimize PK parameters, and reduce drug-drug interactions (DDIs).

Custom ADME/DMPK Services

Ace Therapeutics has a range of capabilities and experience to support the discovery and development of stroke drug candidates. We provide rapid turnaround of high-quality critical DMPK datasets to support key decisions that advance the further development of potential stroke therapeutics.

• High-Throughput ADME Screening Services for Stroke Drug Discovery and Development
• In Vitro ADME Services for Stroke Drug Discovery and Development
• In Vivo ADME Services for Stroke Drug Discovery and Development
• PK/TK Analysis in Stroke Drug Discovery and Development
• Trans-BBB PK Analysis in Stroke Drug Discovery and Development
• PK/PD Analysis Service for Stroke Discovery and Development
• Bioanalytical Services for Stroke Drugs
• Metabolite Identification and Profiling in Stroke Drug Discovery and Development
• Neurochemistry Service in Stroke Drug Discovery & Development

Why Choose Us

• Committed to quality and efficiency, we work closely with clients to provide customized ADME DMPK solutions for different phases of stroke drug discovery and development based their projects.
• Our services cover the entire DMPK spectrum, from in vitro PK and DDI to in vivo DMPK, biotransformation and metabolite identification, and discovery bioanalysis.
• We use state-of-the-art technology to provide you with reliable data to support the development of safe and effective stroke drugs.
• Our DMPK lab can help you save time, reduce costs, and conserve resources in your stroke drug discovery efforts.

As a stroke drug DMPK service provider, Ace Therapeutics is committed to being the partner of choice for stroke drug discovery and development by providing all clients with high-quality data, precise R&D strategies, and exceptional service to meet each client's unique needs. If you are interested in our services, please do not hesitate to contact us!